Healthcare (Prescription Drugs)

HB 527 amends Utah's pharmacy pricing rules to require pharmacy benefit managers to base reimbursement rates only on drugs rated "A" or "B" in the FDA's Orange Book (or similar ratings) that are not obsolete and generally available in the state. It clarifies key terms like "maximum allowable cost" and "rebate," and grants the Insurance Department authority to create implementing rules. This directly affects pharmacies, pharmacy benefit managers, and insurers by changing how drug reimbursement rates are calculated. The bill does not appropriate funds or create new taxes.